Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# Quadria Capital

Asia’s Leading Healthcare Private Equity Firm

## Sitemaps

- [XML Sitemap](https://quadriacapital.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Quadria Capital OPIM Disclosure Statement 2025](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-capital-opim-disclosure-statement-2025) - Quadria Capital reaffirms its alignment with all nine Operating Principles for Impact Management and continues to apply its Impact Management and Measurement (IMM) framework across the investment lifecycle. Through this framework, the firm systematically manages its impact objectives and strategic priorities, monitors the progress and performance of each investment, and seeks to transparently disclose impact outcomes and lessons learned. Quadria remains focused on delivering measurable healthcare impact across South and Southeast Asia while upholding strong ESG integration, active stewardship, and financial performance.
- [BlueMark Impact Verification Statement 2026](https://quadriacapital.com/publications/esg-and-impact-reports/bluemark-impact-verification-statement-2026) - As a signatory of the Operating Principles for Impact Management (the Impact Principles), Quadria Capital engaged BlueMark to undertake an independent verification of the alignment of Quadria Capital’s impact management (IM) system with the Impact Principles. Quadria Capital’s assets under management covered by the Impact Principles (Covered Assets) totals $1.9 billion, for the year ending 12/2025.
- [Quadria Investing for Impact Report 2025](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-investing-for-impact-report-2025) - We are pleased to present Quadria Capital’s Investing for Impact Report 2025, showcasing another year of progress in advancing more resilient, inclusive, and accessible healthcare systems across Asia. The report highlights the measurable impact delivered by our portfolio companies, whose business models and operational execution continue to expand access, affordability, and quality of care across underserved communities in South and Southeast Asia.
- [Apex Healthcare](https://quadriacapital.com/portfolio/life-sciences/apex-healthcare) - Leading integrated Contract Research, Development and Manufacturing (CRDMO) player serving the global life sciences industry
- [Quadria Capital Selected for ImpactAssets 50 2026](https://quadriacapital.com/publications/esg-and-impact-reports/impact-assets-2026) - Quadria Capital engaged BlueMark to undertake an independent assessment of Quadria Capital Fund III LP (Fund III)’s alignment with impact investing and sustainability best practices. Fund III’s impact approach was evaluated across four key pillars: Strategy, Governance, Management, and Reporting. We are proud to share that Fund III received a Platinum Rating from BlueMark’s Fund Impact Diagnostic (Fund ID), placing the Fund in the top quartile and securing a place on BlueMark’s 2025 Fund ID Leaderboard.
- [Quadria Capital and Co-investors Complete Landmark Take-Private of Apex Healthcare](https://quadriacapital.com/publications/quadria-capital-and-co-investors-complete-landmark-take-private-of-apex-healthcare) - Quadria Capital engaged BlueMark to undertake an independent assessment of Quadria Capital Fund III LP (Fund III)’s alignment with impact investing and sustainability best practices. Fund III’s impact approach was evaluated across four key pillars: Strategy, Governance, Management, and Reporting. We are proud to share that Fund III received a Platinum Rating from BlueMark’s Fund Impact Diagnostic (Fund ID), placing the Fund in the top quartile and securing a place on BlueMark’s 2025 Fund ID Leaderboard.
- [BlueMark Fund ID Verifier Statement 2025](https://quadriacapital.com/publications/esg-and-impact-reports/bluemark-fund-id-verifier-statement-2025) - Quadria Capital engaged BlueMark to undertake an independent assessment of Quadria Capital Fund III LP (Fund III)’s alignment with impact investing and sustainability best practices. Fund III’s impact approach was evaluated across four key pillars: Strategy, Governance, Management, and Reporting. We are proud to share that Fund III received a Platinum Rating from BlueMark’s Fund Impact Diagnostic (Fund ID), placing the Fund in the top quartile and securing a place on BlueMark’s 2025 Fund ID Leaderboard.
- [Quadria Capital Secures Partial Exit in NephroPlus IPO Amid Strong Investor Demand](https://quadriacapital.com/publications/press-releases/quadria-capital-secures-partial-exit-in-nephroplus-ipo-amid-strong-investor-demand) - NEW DELHI / SINGAPORE, December 17, 2025 – Quadria Capital (“Quadria”), one of Asia’s largest healthcare-focused private equity firms, today announced the sale of partial stake in Nephrocare Health Services Limited (“NephroPlus”) as part of the company’s initial public offering (IPO). The transaction enables Quadria to make top return on its investment, one of the firm’s fastest turnarounds, with meaningful value creation achieved within approximately 1.5 years. The shares were listed at a premium of around 7 percent over the issue price of ₹490, underscoring strong investor confidence in Asia’s leading renal care provider.
- [Quadria Achieves Top UN PRI Ratings in Inaugural Year](https://quadriacapital.com/publications/quadria-achieves-top-un-pri-ratings-in-inaugural-year) - We are proud to announce that in our first-ever United Nations Principles for Responsible Investment (UN PRI) Assessment, Quadria has achieved top ratings across key categories, delivering an exceptional outcome in our inaugural year as a PRI signatory.
- [Quadria Capital Awarded Fundraise of the Year 2025 by Singapore Venture & Private Capital Association](https://quadriacapital.com/publications/press-releases/quadria-capital-awarded-fundraise-of-the-year-2025-by-singapore-venture-private-capital-association) - SINGAPORE, September 18, 2025 — Quadria Capital (“Quadria”), one of Asia’s largest healthcare-focused private equity firms, today announced that it has been awarded Fundraise of the Year at the 33rd Annual Singapore Venture & Private Capital Association (“SVCA”) Awards. The recognition honours outstanding achievements in private equity and venture capital across the region and celebrates Quadria’s successful close of Quadria Capital Fund III.
- [Quadria Annual Review 2025-26](https://quadriacapital.com/publications/annual-reviews/quadria-annual-review-2025-26) - To invest in the resilience and growth of Asia’s healthcare sector through strategic partnerships and value-driven capital.
- [Financing The Climate - Health Frontier Emering Opportunities](https://quadriacapital.com/publications/esg-and-impact-reports/financing-the-climate-health-frontier-emering-opportunities) - The report 'Financing the Climate Health Frontier: Emerging Opportunities' offers valuable insights and highlights key opportunities at the intersection of climate change and health. This report is part of the Action for Climate Health (AfCH) Series. AfCH is launched by Quadria Capital as an initiative that aims to foster dialogue at the intersection of climate change and public health, assess the current landscape, and explore strategies for adaptation and resilience.
- [Quadria Impact Strategy 2024](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-impact-strategy-2024) - Quadria Capital is pleased to share its Impact Strategy which reflects our commitment to embedding impact principles across the investment lifecycle, guided by global principles such as the Operating Principles of Impact Management. We aim to deliver strong financial returns while driving measurable social impact. Through our Impact Management and Measurement (IMM) framework—focused on accessibility, affordability, quality, and awareness—we invest in healthcare enterprises that expand access to high-quality, affordable care across South and Southeast Asia.
- [Quadria Responsible Investing Policy Statement 2024](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-responsible-investing-policy-statement-2024) - Quadria Capital is pleased to share its Responsible Investment Policy, which outlines our commitment to embedding ESG and impact considerations across the investment lifecycle. Adhering to globally recognized ESG and impact principles including the United Nations Principles for Responsible Investment and the Operating Principles of Impact Management, this policy reflects our integrated approach to driving sustainable healthcare investments in Asia.
- [Quadria Capital OPIM Disclosure Statement 2024](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-capital-opim-disclosure-statement-2024) - Quadria Capital reaffirms its alignment with the Operating Principles for Impact Management, applying its Impact Management and Measurement framework across all investments. The firm continues to deliver measurable healthcare impact across South and Southeast Asia, while upholding strong ESG integration and financial performance.
- [Quadria Capital Climate Action For Health Report 2024](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-capital-climate-action-for-health-report-2024) - Quadria Capital is pleased to present the Climate Action for Health Report—our first climate disclosure aligned with the Task Force on Climate-related Financial Disclosures (TCFD) Recommendations. The report identifies key fund-level physical, and transition risks and outlines clear assessment criteria to guide climate integration across the investment lifecycle. Aligned with SDG 13, Quadria applies a climate impact multiplier lens within its Impact Management and Measurement (IMM) Framework, viewing climate action not only as a risk mitigation tool but also as a catalyst for innovation, efficiency, and resilience in Asia’s healthcare sector.
- [Straits Orthopaedics Expands Global Footprint with Acquisition of U.S.-Based Medin Technologies, Strengthening Orthopaedic Manufacturing Portfolio](https://quadriacapital.com/publications/press-releases/straits-orthopaedics-expands-global-footprint-with-acquisition-of-u-s-based-medin-technologies-strengthening-orthopaedic-manufacturing-portfolio) - Penang, Malaysia – July 25, 2025 – Straits Orthopaedics (Mfg) Sdn Bhd (“Straits”), a leading Malaysia-based contract manufacturer specializing in the precision machining of orthopaedic implants and surgical instruments, today announced the successful acquisition of Medin Technologies, Inc. (“Medin”), a U.S.-based manufacturer of sterilization cases and trays for the orthopaedic sector operating two facilities in Totowa, New Jersey, and Manchester, New Hampshire.
- [Quadria Capital Closes Oversubscribed US$1 Billion Fund III to Advance Healthcare Transformation Across Asia](https://quadriacapital.com/publications/press-releases/quadria-capital-closes-oversubscribed-us1-billion-fund-iii-to-advance-healthcare-transformation-across-asia) - SINGAPORE, 27 May, 2025 – Quadria Capital, Asia’s premier healthcare-focused private equity firm, today announced the final close of its Fund III with US$1.07 billion in total commitments, significantly exceeding its original $800 million target.
- [Quadria Investing for Impact Report 2024](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-investing-for-impact-report-2024) - We are pleased to present Quadria Capital’s 2024 Annual Impact Report, showcasing our continued commitment to driving measurable healthcare impact across Asia. This year’s report highlights how our portfolio companies have delivered meaningful results while advancing sustainability, equity, and innovation in one of the world’s most dynamic healthcare landscapes.
- [Aragen Life Sciences](https://quadriacapital.com/portfolio/life-sciences/aragen-life-sciences) - Leading integrated Contract Research, Development and Manufacturing (CRDMO) player serving the global life sciences industry
- [NephroPlus](https://quadriacapital.com/portfolio/healthcare-delivery/nephroplus) - Asia’s largest dialysis network with over 450 centers operation
- [Concord Biotech (2023)](https://quadriacapital.com/portfolio/exits/concord-biotech) - Leading global supplier of fermentation based biopharma APIs focussed on niche segments like immunosuppressants and oncology
- [Royal Healthcare (2025)](https://quadriacapital.com/portfolio/exits/royal-healthcare) - One of Singapore’s leading multi-specialty care groups
- [Aragen secures $100 Mn investment from Quadria Capital](https://quadriacapital.com/publications/press-releases/aragen-secures-100-mn-investment-from-quadria-capital) - Aragen Life Sciences is a globally renowned R&D and manufacturing solutions provider to the global life sciences industries. It offers a range of solutions across the drug discovery, development and manufacturing continuum to advance small and large-molecule programs. The Company operates through a global network of eight sites with a team of ~4500 employees and 450+ PhDs. Its expertise and experience have enabled over 400 customers to advance their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally. Visit www.aragen.com for more details.
- [AIG](https://quadriacapital.com/case-studies/aig) - AIG is Asia’s leading referral centre for gastric sciences and globally recognised centre of excellence
- [Quadria Capital partially exits Akums Drugs and Pharmaceuticals through IPO](https://quadriacapital.com/publications/press-releases/quadria-capital-partially-exits-akums-drugs-and-pharmaceuticals-through-ipo) - NEW DELHI / SINGAPORE, August 6, 2024 – Quadria Capital (“Quadria”), one of Asia’s largest healthcare-focused private equity firms, today announced the sale of a 10% stake in Akums Drugs and Pharmaceuticals Ltd. (“Akums”) as part of its initial public offering (IPO).
- [Quadria Annual Review 2024-25](https://quadriacapital.com/publications/annual-reviews/quadria-annual-review-2024-25) - To help build great companies by being a preferred strategic partner and specialized capital provider across Asia.
- [Quadria Capital wins Singapore Venture & Private Capital Association’s Private Equity Deal of the Year for the second year in a row](https://quadriacapital.com/publications/press-releases/quadria-capital-wins-singapore-venture-private-capital-associations-private-equity-deal-of-the-year-for-the-second-year-in-a-row) - Founded in 1996, Maxivision is one of India’s leading and fastest-growing private eye care clinics. It operates 50 centres in five states across South and West India, including Telangana, Andhra Pradesh, Gujarat, Kerala, and Tamil Nadu. The company offers a full suite of neonatal, paediatric, and geriatric eye care services, including cataract surgery, LASIK and ReLEx Smile treatments, treatments for retinal issues and glaucoma, and oculoplasty.
- [Maxivision](https://quadriacapital.com/case-studies/maxivision) - Maxivision is one of India’s leading and fastest growing private eye care chains
- [FV Hospital](https://quadriacapital.com/case-studies/fv-hospital) - FV Hospital is a leading multi-disciplinary tertiary care provider in Vietnam
- [Hermina](https://quadriacapital.com/case-studies/hermina) - Hermina is a leading private hospital group in Indonesia, dedicated to delivering quality, affordable healthcare
- [FV Hospital (2023)](https://quadriacapital.com/portfolio/exits/fv-hospital-2) - Leading JCI accredited hospital providing high quality care to the population in Ho Chi Minh City and the surrounding region of South Vietnam
- [NephroPlus Case Study](https://quadriacapital.com/publications/videos/nephroplus-case-study) - NephroPlus is India's largest network of dialysis clinics. This film explains how Quadria’s partnership with NephroPlus is helping the company to expand and bring essential dialysis services to more patients in India and across Asia.
- [Investing for Impact](https://quadriacapital.com/publications/videos/investing-for-impact) - Quadria Capital is committed to changing healthcare. For more than a decade, Quadria has invested in emerging leaders across South and Southeast Asia to help expand access to quality and affordable care, bringing critical services to the underserved communities that need them most.
- [Hermina Case Study](https://quadriacapital.com/publications/videos/hermina-case-study) - Hermina Hospital Group is a leading private hospital group in Indonesia. This film explores how Quadria’s investment in Hermina is supporting quality, affordable healthcare across the country.
- [Akums Drugs and Pharmaceuticals (Partial Exit 2024)](https://quadriacapital.com/portfolio/life-sciences/akums-drugs-and-pharmaceuticals) - India’s largest pharma contract manufacturing (CDMO) company, with 30% share of the domestic CDMO market
- [Lablink (2021)](https://quadriacapital.com/portfolio/exits/lablink) - Leading hospital laboratory chain in Malaysia committed to enhancing the standards of care by delivering reliable and quality diagnostics services across Malaysia and the surrounding region
- [Strand Life Sciences (2021)](https://quadriacapital.com/portfolio/exits/strand-life-sciences) - India’s Leading Integrated, Specialized Diagnostic Company With Strong Global Bioinformatics & Clinical Research Capabilities
- [Asian Institute of Gastroenterology (2022)](https://quadriacapital.com/portfolio/exits/asian-institute-of-gastroenterology) - One of South Asia’s leading gastric sciences hospital and amongst the 14 centres globally to be recognized as Centre of Excellence by World Endoscopy Organization
- [SOHO Global Health (2020)](https://quadriacapital.com/portfolio/exits/soho-global-health) - Leading integrated pharmaceuticals group in Indonesia, the fourth most populous country in the world with more than 250 million people
- [Medica Superspeciality Hospital (2021)](https://quadriacapital.com/portfolio/exits/medica-superspeciality-hospital) - Leading network of hospitals across East India with a presence across the region including the NABH/NABL accredited super specialty hospital in Kolkata
- [Straits Orthopaedics](https://quadriacapital.com/portfolio/medical-devices/straits-orthopaedics) - Leading orthopaedic-focused Contract Development and Manufacturing Organization (CDMO) in Malaysia
- [Encube Ethicals](https://quadriacapital.com/portfolio/life-sciences/encube-ethicals) - Leading global player engaged in manufacturing and marketing of topical drugs
- [Hermina Hospitals](https://quadriacapital.com/portfolio/healthcare-delivery/hermina-hospitals) - One of Indonesia’s largest hospital groups
- [Quadria Capital OPIM Disclosure Statement 2023](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-capital-opim-disclosure-statement-2023) - In the 10 years since Quadria Capital was founded, it has remained steadfast in its core belief that access to healthcare is a fundamental human right by contributing to transform its availability and affordability across Asia’s emerging regions.
- [BlueMark Impact Verification Statement 2023](https://quadriacapital.com/publications/esg-and-impact-reports/bluemark-impact-verification-statement-2023) - As a signatory of the Operating Principles for Impact Management (the Impact Principles)1, Quadria Capital engaged BlueMark to undertake an independent verification of the alignment of Quadria Capital’s impact management (IM) system with the Impact Principles. Quadria Capital’s assets under management covered by the Impact Principles (Covered Assets) totals $1.28 billion, for the period ending 12/2023.
- [Quadria Impact Report 2022](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-impact-report-2022) - At Quadria, we believe quality healthcare is a fundamental human right that should be available, accessible, and affordable for all. Committed to contributing to society, our portfolio companies have consistently made a significant impact.
- [Quadria Investing for Impact Report 2023](https://quadriacapital.com/publications/esg-and-impact-reports/quadria-investing-for-impact-report-2023) - We are delighted to present our 2023 annual impact report to all stakeholders. It underscores our continuous commitment to the investment industry, our partners, and stakeholders, as we aim to transparently communicate the progress made by both Quadria and our investee companies in achieving measurable societal and environmental outcomes over time.
- [Quadria Capital acquires stake in leading Singapore multi-specialty medical group, MWH holdings](https://quadriacapital.com/publications/press-releases/quadria-capital-acquires-stake-in-leading-singapore-multi-specialty-medical-group-mwh-holdings) - Quadria’s investment and partnership to spearhead MWH’s regional expansion by bringing high quality and affordable multi-specialty care to region with huge unmet demand
- [Quadria Capital buys majority stake in Indian hospital chain](https://quadriacapital.com/publications/in-the-news/quadria-capital-buys-majority-stake-in-indian-hospital-chain) - Quadria Capital buys majority stake in Indian hospital chain
- [Quadria Capital raises 304 million US dollars to support healthcare in Asia](https://quadriacapital.com/publications/in-the-news/quadria-capital-raises-304-million-us-dollars-to-support-healthcare-in-asia) - Quadria Capital has raised 304 million US dollars for healthcare investments in Asia with a strong support from premier investors and institutions with healthcare expertise.
- [Singapore's Quadria Capital to invest US $304 million in Asian healthcare](https://quadriacapital.com/publications/in-the-news/singapores-quadria-capital-to-invest-us-304-million-in-asian-healthcare) - A Singapore-based private equity firm would invest one-third of its recently raised US $304 million in the South Asian healthcare sector
- [Quadria Capital raises $304m for Asia healthcare investments](https://quadriacapital.com/publications/in-the-news/quadria-capital-raises-304m-for-asia-healthcare-investments) - Singapore and India-based private equity firm Quadria Capital said it had raised $304 million for healthcare investments in South and Southeast Asia.
- [Quadria Capital consortium acquires stake in ‘Concord Biotech’](https://quadriacapital.com/publications/in-the-news/quadria-capital-consortium-acquires-stake-in-concord-biotech) - Quadria Capital, through its Singapore based SPV, Helix Investments Pvt. Limited has successfully concluded an investment deal in Concord Biotech Ltd.
- [Healthcare-focussed PE firm Quadria lines up $9.8-million fund for India](https://quadriacapital.com/publications/in-the-news/healthcare-focussed-pe-firm-quadria-lines-up-9-8-million-fund-for-india) - Has invested in 15 companies across six Asian countries, through three private-equity vehicles, and manages $1.5 billion of funds
- [Telemedicine emerging as a growth driver in healthcare](https://quadriacapital.com/publications/in-the-news/telemedicine-emerging-as-a-growth-driver-in-healthcare) - A combination of poor last-mile healthcare delivery and an easy access to technology has made telemedicine a strong growth story in the healthcare industry, according to Amit Varma, Managing Partner at Quadria Capital.
- [Digital Health Opportunities](https://quadriacapital.com/publications/in-the-news/digital-health-opportunities) - The article focuses on how digital health is helping manage chronic conditions through the use of technology and the solutions that are being developed keeping in mind the aging population globally.
- [HealthCare atHOME raises $40 million from PE firm Quadria Capital](https://quadriacapital.com/publications/in-the-news/healthcare-athome-raises-40-million-from-pe-firm-quadria-capital) - Sector expected to grow to $280 bn by 2020, home-health care is expected to contribute $8.4 bn
- [Home-healthcare services see increased interest from venture capitalists](https://quadriacapital.com/publications/in-the-news/home-healthcare-services-see-increased-interest-from-venture-capitalists) - Rise in chronic illness, coupled with hospitals’ inability to deal with rising volumes is opening up business opportunities for firms
- [Quadria invests Singapore, Vietnam hospitals](https://quadriacapital.com/publications/in-the-news/quadria-invests-singapore-vietnam-hospitals) - Healthcare-focused private equity firm Quadria Capital has acquired stakes in Singapore medical center operator MWH Holdings and Vietnam’s FV Hospital.
- [Beyond Metros](https://quadriacapital.com/publications/in-the-news/beyond-metros) - Private hospitals, offering quality healthcare, are proliferating in Tier-II and Tier-III towns.
- [Quadria Capital backs Malaysian diagnostics provider Lablink](https://quadriacapital.com/publications/in-the-news/quadria-capital-backs-malaysian-diagnostics-provider-lablink) - Asia-focused healthcare investor Quadria Capital today announced its investment in Malaysian diagnostics provider Lablink (M) Sdn Bhd.
- [Strand Life Sciences closes $13-million financing led by Quadria Capital](https://quadriacapital.com/publications/in-the-news/strand-life-sciences-closes-13-million-financing-led-by-quadria-capital) - Strand Life Sciences announced an investment by Quadria Capital, Asia’s leading healthcare focused private equity investor.
- [We target firms with holistic healthcare view: Quadria Capital co-founder](https://quadriacapital.com/publications/in-the-news/we-target-firms-with-holistic-healthcare-view-quadria-capital-co-founder) - In an interview, Amit Varma explains what sets his healthcare-focused fund apart from other players in the market.
- [Health-tech startup funding hits all-time high of $510 million in 2018](https://quadriacapital.com/publications/in-the-news/health-tech-startup-funding-hits-all-time-high-of-510-million-in-2018) - Healthcare schemes, such as Ayushman Bharat, have also put the spotlight on healthcare, leading to positive sentiments even among startups, said Amit Varma, managing partner, Quadria Capital
- [Experts Debate On Quality Vs Cost In Diagnostics Industry And Kind Of Regulation Needed](https://quadriacapital.com/publications/in-the-news/experts-debate-on-quality-vs-cost-in-diagnostics-industry-and-kind-of-regulation-needed) - At the event, a panel discussion was organized on the ‘Quality vs cost in the diagnostics industry and the needed regulation’.
- [Make your investments sustainable](https://quadriacapital.com/publications/in-the-news/make-your-investments-sustainable) - Globally, out of US$80 trillion assets under management in the capital markets, over US$30 trillion are sustainable assets.
- [Quadria Capital servicing healthcare companies](https://quadriacapital.com/publications/in-the-news/quadria-capital-servicing-healthcare-companies) - Amit Varma is the Managing Partner of Quadria Capital, a US$304 mn healthcare focused private equity fund that invests in healthcare sector across Southeast Asia.
- [Singapore-based PE gets world's first fund financing based on sustainability performance: ING](https://quadriacapital.com/publications/in-the-news/singapore-based-pe-gets-worlds-first-fund-financing-based-on-sustainability-performance-ing) - NG on Friday said it has introduced the world's first sustainability improvement fund financing for a Singapore-based private equity fund, Quadria Capital, reflecting the rising interest from the financing sector in factoring in environmental, social and governance (ESG) in capital-raising activities.
- [Fintech, data science company Oriente secures US$20M from SIlverhorn Group, and Quadria Capital announces US$595M second fund](https://quadriacapital.com/publications/in-the-news/fintech-data-science-company-oriente-secures-us20m-from-silverhorn-group-and-quadria-capital-announces-us595m-second-fund) - Quadria Capital, an independent healthcare-focused private equity firm in Asia, has announced the closing of its latest fund, exceeding the US$400-million target
- [Quadria Capital currently manages total active capital of over US$1 billion](https://quadriacapital.com/publications/in-the-news/quadria-capital-currently-manages-total-active-capital-of-over-us1) - And has made over 20 investments in healthcare businesses across Asia.
- [Singapore-based Quadria Capital raises $595 million fund for healthcare-focused deals](https://quadriacapital.com/publications/in-the-news/singapore-based-quadria-capital-raises-595-million-fund-for-healthcare-focused-deals) - Singapore-based private equity firm Quadria Capital has closed its second fund at its maximum of $595 million, it said on Wednesday.
- [Healthcare focused PE firm Quadria Capital closes $595m second fund](https://quadriacapital.com/publications/in-the-news/healthcare-focused-pe-firm-quadria-capital-closes-595m-second-fund) - Healthcare focused private equity firm Quadria Capital has closed its second fund, Quadria Capital Fund II at $595 million, according to a press statement from the company.
- [Singapore-based Quadria Capital raises $595 million fund for healthcare-focused deals](https://quadriacapital.com/publications/in-the-news/singapore-based-quadria-capital-raises-595-million-fund-for-healthcare-focused-deals-2) - The firm, which focuses on healthcare investments around South and Southeast Asia, said in a statement that the amount raised exceeded its initial $400 million target.
- [Singapore-based Quadria Capital raises $595 million fund for healthcare-focused deals](https://quadriacapital.com/publications/in-the-news/singapore-based-quadria-capital-raises-595-million-fund-for-healthcare-focused-deals-3) - Singapore-based private equity firm Quadria Capital has closed its second fund at its maximum fund size of $595 million, it said on Wednesday.
- [Quadria Capital Hits Final Close Of Second Healthcare Fund, Overshoots Target](https://quadriacapital.com/publications/in-the-news/quadria-capital-hits-final-close-of-second-healthcare-fund-overshoots-target) - Singapore and Delhi based private equity firm Quadria Capital has marked the final close of its second healthcare-focused fund at $595 million (Rs 4346.84 crore), overshooting its initial target to raise $400 million.
- [Quadria Capital Acquires Stake in Hygiene Products Maker Nobel Hygiene](https://quadriacapital.com/publications/in-the-news/quadria-capital-acquires-stake-in-hygiene-products-maker-nobel-hygiene) - Quadria Capital now becomes the largest minority shareholder, adding a consumer healthcare-focused company into its portfolio
- [Nobel Hygiene raises Rs 450 crore in funding led by Quadria Capital](https://quadriacapital.com/publications/in-the-news/nobel-hygiene-raises-rs-450-crore-in-funding-led-by-quadria-capital) - The deal is a mix of primary and secondary capital where existing angel and PE investors including CLSA Capital Partners, Access India fund and its co-investors will exit
- [Encube Ethicals gets funding from Quadria Capital, others at $800 million valuation](https://quadriacapital.com/publications/in-the-news/encube-ethicals-gets-funding-from-quadria-capital-others-at-800-million-valuation) - Encube Ethicals’ funding round, that saw participation of Quadria Capital and Gulf Islamic Investments, provides an exit to early backer Renuka Ramnath-led Multiples Private Equity.
- [Quadria to pick stake in Encube](https://quadriacapital.com/publications/in-the-news/quadria-to-pick-stake-in-encube) - Healthcare focused private equity firm Quadria Capital along with its co-investors, including Gulf Islamic Investments, has committed over $100 million for a minority stake in Encube Ethicals
- [Asia’s largest healthcare-focused fund sees a pandemic opportunity in India](https://quadriacapital.com/publications/in-the-news/asias-largest-healthcare-focused-fund-sees-a-pandemic-opportunity-in-india) - Quadria Capital, which has backed Nobel Hygiene and Encube Ethicals within the last one week, plans to deploy $400-500 million in India over the next 18-24 months.
- [Digital Health Platform MediBuddy Racks Up $125 Mn Co-Led By Quadria, Lightrock](https://quadriacapital.com/publications/in-the-news/digital-health-platform-medibuddy-racks-up-125-mn-co-led-by-quadria-lightrock) - Online health platform MediBuddy, operated by Phasorz Technology Pvt Ltd, on Tuesday said it has bagged $125 million in a Series C funding co-led by Quadria Capital and Lightrock India.
- [Digital healthcare company MediBuddy raises $125 million](https://quadriacapital.com/publications/in-the-news/digital-healthcare-company-medibuddy-raises-125-million) - Digital healthcare venture MediBuddy has raised $125 million in Series C funding from Quadria Capital and Lightrock India, along with participation from existing investors Bessemer Venture Partners, India Life Sciences Fund III, Rebright Partners and others.
- [Annual Review For 2014](https://quadriacapital.com/publications/annual-reviews/annual-review-for-2014) - Founded in 2008, Quadria has invested over US$ 875 million in 13 companies across six countries in the region, through three private equity vehicles.
- [Annual Report for 2016](https://quadriacapital.com/publications/annual-reviews/annual-report-for-2016) - We create opportunities for investors who want to know that as their money is working smart, it is also making a difference in people’s everyday lives.
- [Annual Report for 2017](https://quadriacapital.com/publications/annual-reviews/annual-report-for-2017) - We invest in what we understand and leverage our deep domain knowledge, dedicated healthcare team and proprietary healthcare ecosystem for growth.
- [Healthcare Thought Leadership](https://quadriacapital.com/publications/esg-and-impact-reports/healthcare-thought-leadership) - The global center of gravity of the healthcare industry is shifting rapidly. By early next decade, total healthcare spend in Asia will exceed US$4 trillion and will represent a market opportunity larger than the US and Europe today.
- [Social Impact Thought Leadership](https://quadriacapital.com/publications/esg-and-impact-reports/social-impact-thought-leadership) - Quadria Capital is proud to invest in businesses that are proactively working to address these pressing challenges around healthcare provisioning in the region. We believe that responsible and impact oriented investment is critical to long term, sustainable value creation in the region.
- [Annual ESG Report 2018](https://quadriacapital.com/publications/esg-and-impact-reports/annual-esg-report-2018) - At Quadria, we believe quality healthcare is a fundamental human right that should be available, accessible, and affordable for all. Committed to contributing to society, our portfolio companies have consistently made a significant impact.
- [Quadria Annual Review 2018-19](https://quadriacapital.com/publications/annual-reviews/quadria-annual-review-2018-19) - Our commitment to offer healthcare products and services with demonstrated potential for excellence has enhanced our reputation as a trusted investment partner.
- [Quadria Annual Review 2019-20](https://quadriacapital.com/publications/annual-reviews/quadria-annual-review-2019-20) - Quadria’s strategic investment and cultivation of best-in-class healthcare assets with strong fundamentals underpin stable, steady and sustainable returns.
- [Quadria Annual Review 2020-21](https://quadriacapital.com/publications/annual-reviews/quadria-annual-review-2020-21) - We partner with resilient companies which can steer through unchartered territories to seamlessly adapt to new business conditions.
- [Quadria Annual Review 2022-23](https://quadriacapital.com/publications/annual-reviews/quadria-annual-review-2022-23) - We help growth companies bolster their strengths to create a competitive moat and amplify opportunities to redefine the future of healthcare today
- [Quadria Annual Review 2023-24](https://quadriacapital.com/publications/annual-reviews/quadria-annual-review-2023-24) - We create value not just through our individual investments, but in the networks we create. By combining our deep expertise in the healthcare sector with strategic investments and operational excellence, we strive to transform and improve the availability of healthcare products and services – particularly in underserved communities where the impact is greatest.
- [Dr. Amit Varma, co-founder and managing partner of Quadria Capital on pitching to cautious LPs](https://quadriacapital.com/publications/videos/dr-amit-varma-co-founder-and-managing-partner-of-quadria-capital-on-pitching-to-cautious-lps) - VCCircle caught up with Dr. Amit Varma in this rare interview to discuss with him what motivated him to go for this transition in his career, fund raising environment in the country right now and what is making LPs nervous to invest in sector specific funds like Quadria.
- [Dr Amit Varma speaking on the topic Preparing for Private Equity](https://quadriacapital.com/publications/videos/dr-amit-varma-speaking-on-the-topic-preparing-for-private-equity) - Dr Amit Varma speaking on the topic Preparing for Private Equity
- [Quadria Capital managing partner on fundraising, investing in health tech and more](https://quadriacapital.com/publications/videos/quadria-capital-managing-partner-on-fundraising-investing-in-health-tech-and-more) - Amit Varma, managing partner at Quadria Capital, talks about how the healthcare focused private equity firm closed its $300 million fund in the middle of last year amid a "brutal fundraising environment".
- [Quadria Capital's Amit Varma on attractive segments in healthcare for new VC fund](https://quadriacapital.com/publications/videos/quadria-capitals-amit-varma-on-attractive-segments-in-healthcare-for-new-vc-fund) - In this video interview Amit Varma, managing partner at Quadria Capital elaborates on investments plans from the new fund.
- [Quadria Capital's Amit Varma on the new fund, exits and more](https://quadriacapital.com/publications/videos/quadria-capitals-amit-varma-on-the-new-fund-exits-and-more) - In a freewheeling interaction with VCCTV, Amit Varma, managing partner at Quadria Capital, said that the ticket size from its new fund will increase up to $75 million.
- [Quadria's Abrar Mir on "the future of and opportunities within healthcare in Asia" - Part-1](https://quadriacapital.com/publications/videos/quadrias-abrar-mir-on-the-future-of-and-opportunities-within-healthcare-in-asia-part-1) - Part 1 of 'In the Boardroom' interview with Quadria Capital's Abrar Mir
- [Story of Quadria Capital - Focus Healthcare Impact](https://quadriacapital.com/publications/videos/story-of-quadria-capital-focus-healthcare-impact) - We have a unique opportunity to invest in sustainable healthcare in Asia. Our businesses are making an enormous social impact on the development of communities and have the power to generate superior returns for our investors.
- [Quadria's Abrar Mir on "the future of and opportunities within healthcare in Asia" - Part-2](https://quadriacapital.com/publications/videos/quadrias-abrar-mir-on-the-future-of-and-opportunities-within-healthcare-in-asia-part-2) - Part 2 of 'In the Boardroom' interview with Quadria Capital's Abrar Mir
- [Quadria Capital closes Asia’s first social loan to support healthcare investments in South and Southeast Asia](https://quadriacapital.com/publications/press-releases/quadria-capital-closes-asias-first-social-loan-to-support-healthcare-investments-in-south-and-southeast-asia) - A revolving credit facility of up to $200 million, to finance its investments in healthcare, pharmaceutical and diagnostic assets that improve access to healthcare across South Asia and Southeast Asia.
- [Quadria Capital completes successful exit of Concord Biotech through IPO](https://quadriacapital.com/publications/press-releases/quadria-capital-completes-successful-exit-of-concord-biotech-through-ipo) - The offering size of INR 15.5 billion (US$187 million) was one of the largest pharma IPOs in the last two years and was priced at INR 741 per share.
- [Quadria Capital awarded PE Deal of the Year 2023 by Singapore Venture & Private Capital Association](https://quadriacapital.com/publications/press-releases/quadria-capital-awarded-pe-deal-of-the-year-2023-by-singapore-venture-private-capital-association) - Announced that it has been awarded “PE Deal of the Year” at the 31st Annual Singapore Venture & Private Capital Association (“SVCA”) Awards for its acquisition of a majority stake in Straits Orthopaedics
- [Quadria Capital raises nearly US$ 500 million for first close of Asia healthcare fund](https://quadriacapital.com/publications/press-releases/quadria-capital-raises-nearly-us-500-million-for-first-close-of-asia-healthcare-fund) - The fund will continue the firm’s focus on providing growth capital to promising companies to address the need for quality, accessible and equitable healthcare across Asia.
- [Quadria Capital becomes signatory of United Nations-Supported Principles for Responsible Investment](https://quadriacapital.com/publications/press-releases/quadria-capital-becomes-signatory-of-united-nations-supported-principles-for-responsible-investment) - It marks another step in the firm’s ongoing commitment to integrate environmental, social and governance (ESG) impact into its investment decisions and portfolio company management.
- [Quadria Capital becomes a signatory to the Operating Principles for Impact Management](https://quadriacapital.com/publications/press-releases/quadria-capital-becomes-a-signatory-to-the-operating-principles-for-impact-management) - Developed by the International Finance Corporation (IFC) in collaboration with other asset managers, asset owners and stakeholders, the Impact Principles are now hosted by the Global Impact Investing Network (GIIN).
- [Quadria Capital Completes US$107 Million First Closing of its Healthcare Fund](https://quadriacapital.com/publications/press-releases/quadria-capital-completes-us107-million-first-closing-of-its-healthcare-fund) - The fund is focused on making growth equity investments in high quality and scalable mid-sized healthcare companies in South and Southeast Asia.
- [Quadria Capital Led Consortium Acquires Stake In Medica Synergie](https://quadriacapital.com/publications/press-releases/quadria-capital-led-consortium-acquires-stake-in-medica-synergie) - Investment to help build Medica into the largest healthcare network in Eastern India
- [SOHO Global Health and Quadria Capital Announce Partnership](https://quadriacapital.com/publications/press-releases/soho-global-health-and-quadria-capital-announce-partnership) - Marks the first private equity investment into an Indonesian pharmaceutical company
- [Quadria Capital raises US$304 Million to support healthcare in Asia](https://quadriacapital.com/publications/press-releases/quadria-capital-raises-us304-million-to-support-healthcare-in-asia) - Singapore-and-India-based private equity firm closes healthcare fund with strong support from premier investors and institutions with healthcare expertise
- [Quadria Capital Acquires Stake In Asian Institute of Gastroenterology](https://quadriacapital.com/publications/press-releases/quadria-capital-acquires-stake-in-asian-institute-of-gastroenterology) - Investment to help build AIG into one of the largest single location gastric sciences hospital in the world
- [Quadria Capital led consortium acquires stake in Concord Biotech](https://quadriacapital.com/publications/press-releases/quadria-capital-led-consortium-acquires-stake-in-concord-biotech) - Investment to help build Concord Biotech into a leading integrated biopharmaceutical company focused on high growth niche therapies
- [Quadria Capital named best for the world fund for impact investing in healthcare sector](https://quadriacapital.com/publications/press-releases/quadria-capital-named-best-for-the-world-fund-for-impact-investing-in-healthcare-sector) - Quadria capital the world fund for impact investing in healthcare sector
- [Quadria Capital acquires stake in JCI accredited Veitnam healthcare provider, FV hospital](https://quadriacapital.com/publications/press-releases/quadria-capital-acquires-stake-in-jci-accredited-veitnam-healthcare-provider-fv-hospital) - Investment to help transform FV Hospital into a leading multidisciplinary tertiary care provider in Vietnam.
- [Quadria Capital partners leading malaysian diagnostics provider Lablink](https://quadriacapital.com/publications/press-releases/quadria-capital-partners-leading-malaysian-diagnostics-provider-lablink) - Investment to help Lablink grow into leading diagnostics provider across Southeast Asia.
- [Quadria Capital Invests In India’s Leading Specialized Diagnostics Firm Strand Lifesciences](https://quadriacapital.com/publications/press-releases/quadria-capital-invests-in-indias-leading-specialized-diagnostics-firm-strand-lifesciences) - Investment to help transform Strand Life Sciences into Asia’s leading integrated specialised diagnostic and genomic research company
- [Quadria Capital announces second fund of US$595 million](https://quadriacapital.com/publications/press-releases/quadria-capital-announces-second-fund-of-us595-million) - Largest dedicated healthcare investor in South and Southeast Asia
- [Quadria Capital acquires minority stake in indonesia’s leading hospital group, Hermina Hospitals](https://quadriacapital.com/publications/press-releases/quadria-capital-acquires-minority-stake-in-indonesias-leading-hospital-group-hermina-hospitals) - Quadria’s investment and partnership to help transform Hermina into leading tertiary hospital group in Asia
- [Nobel Hygiene Announces Completion of Growth Investment By Quadria Capital](https://quadriacapital.com/publications/press-releases/nobel-hygiene-announces-completion-of-growth-investment-by-quadria-capital) - Quadria Capital now becomes the largest minority shareholder, adding a consumer healthcare focused company into its portfolio.
- [Quadria Capital-led consortium acquires stake in leading global topical drugs manufacturer, Encube Ethicals](https://quadriacapital.com/publications/press-releases/quadria-capital-led-consortium-acquires-stake-in-leading-global-topical-drugs-manufacturer-encube-ethicals) - Quadria’s investment to help catalyse Encube’s growth into a leading integrated topicals-focused company
- [Quadria Capital Invests US$90 million Into Con Cung – Vietnam’s Leading Mom and Baby Retailer](https://quadriacapital.com/publications/press-releases/quadria-capital-invests-us90-million-into-con-cung-vietnams-leading-mom-and-baby-retailer) - The Vietnam-based retail chain for maternity and baby-care products will use the fresh funds to expand its local footprint and develop a super app for millions of Vietnamese mothers
- [Quadria Capital acquires a majority stake in Straits Orthopaedics](https://quadriacapital.com/publications/press-releases/quadria-capital-acquires-a-majority-stake-in-straits-orthopaedics) - Announced today that it has acquired a majority stake in Straits Orthopaedics, a Penang-based global contract manufacturer of orthopaedic-focused medical device solutions, from Mr. TH Su, founder of Straits Orthopaedics, and Apex Healthcare Bhd.
- [Quadria Capital sells stake in JCI accredited Vietnam healthcare provider, FV hospital](https://quadriacapital.com/publications/press-releases/quadria-capital-sells-stake-in-jci-accredited-vietnam-healthcare-provider-fv-hospital) - Through an affiliated entity, it has entered into a definitive agreement for the sale of 100% of its interest in FV Hospital (“FV”) to Thomson Medical Group for a total consideration of up to USD381.4 million, marking the country’s biggest healthcare transaction to-date and Southeast Asia’s largest healthcare acquisition since 2020.
- [Quadria Capital invests in Maxivision Eye Hospital](https://quadriacapital.com/publications/press-releases/quadria-capital-invests-in-maxivision-eye-hospital) - Quadria Capital invests in Maxivision Eye Hospital to drive organic expansion and accelerate inorganic partnerships to cement Maxivision’s position as one of India’s leading eye care platforms
- [Quadria Capital invests in Asia’s leading dialysis service network NephroPlus](https://quadriacapital.com/publications/press-releases/quadria-capital-invests-in-asias-leading-dialysis-service-network-nephroplus) - Founded in 2010, NephroPlus is a uniquely positioned dialysis provider operating in sizeable, high-growth markets across Asia with dominant leadership in India and a fast-growing footprint in the Philippines and other Asian countries.
- [Maxivision Eye Hospitals](https://quadriacapital.com/portfolio/healthcare-delivery/maxivision-eye-hospitals) - One of India’s fastest-growing eye care chains
- [Con Cung](https://quadriacapital.com/portfolio/healthcare-services/con-cung) - Vietnam’s largest mother-and-baby retail and wellness platform
- [MediBuddy](https://quadriacapital.com/portfolio/healthcare-services/medibuddy) - India's leading digital enterprise health management platform
- [Nobel Hygiene](https://quadriacapital.com/portfolio/healthcare-services/nobel-hygiene) - India’s leading player in the personal hygiene market with portfolio of reliable, high-quality and affordable products
- [HealthCare at Home India](https://quadriacapital.com/portfolio/healthcare-services/healthcare-at-home-india) - India’s leading integrated home healthcare service platform with core focus on providing clinical and pharma services to the patients in their homes

## Pages

- [Home](https://quadriacapital.com/) - Discover Quadria Capital, a top private equity firm in India and Singapore, dedicated to advancing healthcare through impactful investments and innovative solutions.
- [About](https://quadriacapital.com/about-quadria-capital) - Discover top private equity firms in Singapore with insights from Abrar Mir, Sunil Thakur, Ewan Davis, Rahul Agarwal, and Dr. Amit Varma.
- [Annual General Meeting 2025](https://quadriacapital.com/agm2025) - About The Event Quadria Capital extends its sincere appreciation for your participation in the 2025 AGM and Healthcare Forum With this year’s theme “Investing in Resilience, Growth in Asia,” our AGM opened with the Partners’ Review on Quadria’s performance, progress, and strategic outlook. We also shared on-the-ground insights into healthcare deal activity across India and
- [Privacy Policy](https://quadriacapital.com/privacy) - Quadria is committed to ensuring the privacy and security of personal data we may collect and process.
- [Contact](https://quadriacapital.com/contact) - Get in touch with the Quadria team via the channels here.
- [Impact and ESG](https://quadriacapital.com/impact) - Discover how Quadria Capital creates lasting impact in Asia by empowering healthcare providers, enhancing patient care, and promoting sustainable growth in the industry.
- [Portfolio](https://quadriacapital.com/portfolio) - Explore the landscape of private equity in Asia, with a spotlight on India. Discover investment opportunities and trends shaping the region's growth.
- [Approach](https://quadriacapital.com/approach) - Discover the impact of healthcare investment and private equity in India. Explore equity investment opportunities that drive innovation and growth in the sector.
- [404](https://quadriacapital.com/404-2) - Oops! Page not found It looks like nothing was found at this location. Back to Home
- [Terms](https://quadriacapital.com/terms) - Please read these terms and conditions of use carefully before using the Site.
- [Publications](https://quadriacapital.com/publications) - Discover our news & industry insights on current trends and challenges.
- [Careers](https://quadriacapital.com/careers) - As Southeast Asia’s leading healthcare private equity firm, we are seeking exceptional individuals to join Quadria in our mission to transform healthcare in Asia.

## Categories

- [Portfolio](https://quadriacapital.com/category/portfolio)
- [Life Sciences](https://quadriacapital.com/category/portfolio/life-sciences)
- [Associated Healthcare Services](https://quadriacapital.com/category/portfolio/healthcare-services)
- [Healthcare Delivery](https://quadriacapital.com/category/portfolio/healthcare-delivery)
- [Medical Devices](https://quadriacapital.com/category/portfolio/medical-devices)
- [Exits](https://quadriacapital.com/category/portfolio/exits)
- [Publications](https://quadriacapital.com/category/publications)
- [Press Releases](https://quadriacapital.com/category/publications/press-releases)
- [Annual Reviews](https://quadriacapital.com/category/publications/annual-reviews)
- [ESG and Impact Reports](https://quadriacapital.com/category/publications/esg-and-impact-reports)
- [Videos](https://quadriacapital.com/category/publications/videos)
- [In the News](https://quadriacapital.com/category/publications/in-the-news)
- [Case Studies](https://quadriacapital.com/category/case-studies)
- [Reports](https://quadriacapital.com/category/publications/esg-and-impact-reports/reports)
- [Governance and Management](https://quadriacapital.com/category/publications/esg-and-impact-reports/governance-and-management)
- [Public Disclosures](https://quadriacapital.com/category/publications/esg-and-impact-reports/public-disclosures)